BOSTON, MA--(Marketwire - May 11, 2009) - WorldCare Clinical, LLC (WCC), a leading imaging
CRO for clinical trials in the pharmaceutical, biotechnology and medical
device industries, today announced that Dr. Asli Memisoglu has joined the
organization as director of biostatistics and data management. In this new
position, Memisoglu will oversee the development of image analysis
performance metrics, statistical design and database management between
WCC's project managers, its sponsors and independent reviewers.
An accomplished biostatistician and scientist with more than ten years of
statistical analysis and programming experience, Memisoglu will bring her
expertise in imaging trial design and analysis to WCC. She will be
responsible for all statistical analysis and database development within
WCC, as well as assisting in the development of imaging charters and
contributing to WCC's enhanced reader training, testing and monitoring
services.
WCC Managing Director Michael O'Brien says, "Despite the economic climate,
WCC is experiencing a growth spurt. Asli's hiring is the culmination of our
plan to build an experienced team of operational experts who understand
both the regulatory requirement and science behind imaging trials. Asli's
appointment marks our fourth new executive hire in six months. We've worked
diligently to put the appropriate mix and level of expertise in place to
complete our operational management team and usher WCC into its next growth
phase."
Prior to joining WCC, Memisoglu served as associate director of
biostatistics at Acusphere Inc., Clinical Research, where she managed all
biostatistical and data management aspects of Acusphere's clinical trials.
Memisoglu also held the position of medical communications scientist while
at Acusphere. Previous to Acusphere, she was a biostatician and lead
pharmacoeconomist/outcomes scientist for Abt Associates' Health Economics
and Quality of Life Evaluation Services, designing and implementing
outcomes research projects for pharmaceutical and biotechnology companies.
She currently serves on the board of directors for the Boston Chapter of
the Healthcare Businesswomen's Association and is co-director of Women in
Science Affinity Group. She is also a long-time member of the steering
committee for the Boston Area SAS® Users Group and serves as its SAS
liaison. Memisoglu holds a doctorate in molecular science and cellular
toxicology and a master's degree in epidemiology from Harvard University,
and a bachelor's degree in biology from Tufts University.
About WorldCare Clinical
WorldCare Clinical (WCC) is a leading imaging CRO for clinical trials in
the pharmaceutical, biotechnology, and medical device industries. With a
seventeen year heritage specializing in imaging, WCC has processed more
than 1 million images and enrolled 4,000 sites in over 50 countries.
Combining extensive medical, operational and image management expertise,
WCC offers support for every facet of an imaging clinical trial. From
complete trial management and archiving to select services such as study
design, Imaging Charter development, and the creation of an imaging
library, WCC works with sponsors to meet any combination of clinical
imaging needs. For more information, visit www.wcclinical.com.
